Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of verapamil and paroxetine is a drug therapy that has been studied for treating tinnitus. According to a randomized, double-blind, placebo-controlled clinical trial conducted between 2019 and 2023, this combination (referred to as "group VP" in the study) showed promising results in improving tinnitus severity[1][8]. ## Composition and Classification This is a combination drug therapy consisting of two distinct medications: 1. **Verapamil**: A calcium channel blocker primarily used to treat hypertension, angina, and certain cardiac arrhythmias[4]. 2. **Paroxetine**: A selective serotonin reuptake inhibitor (SSRI) antidepressant used to treat major depressive disorder, panic disorder, OCD, social phobia, generalized anxiety disorder, and other conditions[2]. ## Mechanism of Action The therapeutic effect of this combination likely stems from the complementary mechanisms of both drugs: - Verapamil works by blocking calcium channels, which affects vascular smooth muscle and cardiac muscle, leading to vasodilation and reduced cardiac workload[4]. - Paroxetine selectively inhibits the reuptake of serotonin in the central nervous system, increasing serotonin availability at synaptic junctions[2]. Some studies suggest that calcium channel blockers like verapamil may have their own antidepressant-like effects, which could potentially enhance the effects of SSRIs like paroxetine[5]. ## Clinical Evidence In a clinical trial for tinnitus treatment, the verapamil-paroxetine combination demonstrated significant improvement in tinnitus severity. The Tinnitus Functional Index (TFI) score decreased from 54.6 ± 17.5 at baseline to 42.2 ± 16.1 at the end of the 8-week trial (P = .004)[1][8]. ## Potential Interactions There is some conflicting information regarding interactions between these medications: - One source indicates that the metabolism of paroxetine can be decreased when combined with verapamil[2], which could potentially increase paroxetine levels. - Another source states there shouldn't be any significant interactions between paroxetine and verapamil[7]. Given these potential interactions, careful monitoring would be advisable when using this combination. ## Development Status This drug combination has been studied in clinical trials for tinnitus treatment, with promising results suggesting it may be effective in improving tinnitus severity. However, researchers noted that "larger-scale trials with longer follow-up periods are warranted to validate our findings between groups"[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on verapamil + paroxetine.